ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma

Head and neck squamous cell carcinoma (HNSCC) is the sixth most frequent cancer worldwide, and the 5-year survival rates are among the worst of the major cancers. Oncolytic herpes simplex viruses (oHSV) have the potential to make a significant impact in the targeted treatment of these patients. Here...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Oncolytics
Autors principals: Yoo, Ji Young, Yu, Jun-Ge, Kaka, Azeem, Pan, Quintin, Kumar, Pawan, Kumar, Bhavna, Zhang, Jianying, Mazar, Andrew, Teknos, Theodoros N, Kaur, Balveen, Old, Matthew O
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4782961/
https://ncbi.nlm.nih.gov/pubmed/27119105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars